Lab Members
Andrew Dunbar, M.D.
Assistant Professor & Assistant Attending
Dr. Andrew Dunbar is a laboratory-based physician-scientist and principal investigator of an independent translational research lab at MD Anderson which studies clonal evolution and drug resistance in myeloproliferative neoplasms (MPN) and acute myeloid leukemias (AML). Dr. Dunbar has a special interest in using animal models of MPN/AML along with state-of-the-art genomic and epigenomic techniques to uncover the molecular basis of these diseases and to develop investigational compounds that better target biologic vulnerabilities. Ultimately, he hopes to translate his findings into novel drug therapies that improve outcomes for people affected by these conditions.
Dr. Dunbar completed his medical education at New York Medical College, receiving his M.D. in 2012. He subsequently completed his residency in internal medicine at the New York Presbyterian/Weill Cornell Medical Center in New York, NY in 2015, followed by his fellowship in hematology/medical oncology in 2018 at Memorial Sloan-Kettering Cancer Center in New York, NY. Dr. Dunbar joined MD Anderson in January 2024 as an assistant professor in the department of Hematopoietic Biology and Malignancy, with a co-appointment as assistant attending in the department of Leukemia after spending three years as an Instructor of Medicine and Assistant Attending on the Leukemia Service at Memorial Sloan-Kettering Cancer Center in New York. Dr. Dunbar brings with him 15 years of experience in the pre-clinical research and clinical management of MPNs and other myeloid/lymphoid hematologic malignancies and is eager to recruit additional talent and further develop his growing laboratory and clinical practice.
Dr. Dunbar has won numerous awards throughout his career, including some of the following:
- 2024: Andrew Sabin Family Foundation Physician-Scientist Award
- 2024: American Society of Hematology (ASH) Scholar Award
- 2019: Damon Runyon Physician-Scientist Training Award
- 2018: Next Gen Innovator, HemeOncToday
- 2017: American Association of Cancer Research (AACR) Clinical and Translational Cancer Research Fellowship Award
- 2017: American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation Young Investigator Award
- 2016: National Institute of Health F30 (T32) Predoctoral National Research Service Award (NRSA)
- 2012: Cor et Manus Award for Extraordinary Community Service, New York Medical College
Dr. Dunbar is a member of the following professional societies:
- 2015–Present: Active Member, American Societies of Hematology
- 2015–Present: Active Member, American Association of Cancer Research
Linda Fabris, Ph.D.
Senior Research Scientist
Dr. Linda Fabris is a senior research scientist in the department of Hematopoietic Biology and Malignancy at MD Anderson, joining the Dunbar Lab in April 2024. In the Dunbar Lab, her role is to lead and support advanced research projects, design and conduct experiments, analyze complex data and contribute to the development of scientific manuscripts and grant proposals. Dr. Fabris also mentors junior researchers and collaborates with other scientists to drive forward the lab’s scientific objectives. Her research interests focus on the study of non-coding RNAs and their roles in cancer pathogenesis.
Dr. Fabris completed her Ph.D. in medical and biotechnological sciences (oncology) at the University of Udine in 2011. During her doctoral studies, she conducted research at the CRO National Cancer Institute in Aviano, Italy, where she continued as a postdoctoral fellow until 2014. In April 2014, Dr. Fabris joined MD Anderson as a postdoctoral fellow in the department of Experimental Therapeutics. She was promoted to instructor in 2018 and later advanced to her current role as senior research scientist.
Ivo Veletic, M.D.
Instructor
Dr. Ivo Veletic is an instructor in the Leukemia department at MD Anderson. His research focuses on myelofibrosis, myeloproliferative neoplasms and leukemia. In the Dunbar Lab, his work focuses on spatial characterization of patient bone marrow using multiplexed immunofluorescence and other proteomic-based approaches to dissect cell co-localization patterns of myelofibrosis in bone marrow.
Prior to working in the Dunbar Lab, Dr. Veletic worked in the laboratory of Dr. Srdan Verstovsek, a preeminent MPN clinical investigator at MD Anderson, and has authored over 60 publications, accumulating more than 300 citations, in various aspects of MPN research. Dr. Veletic completed his medical training at the University of Zagreb School of Medicine in Croatia, obtaining his M.D. in 2014.
Liam Sloane
Research Assistant I